PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial
- Conditions
- Head and Neck Cancer
- Registration Number
- NCT06809673
- Lead Sponsor
- Ospedale Policlinico San Martino
- Brief Summary
This is a clinical, observational, non-pharmacological, multicenter, prospective case-control no-profit study to assess the prognostic role of several circulating inflammatory biomarkers
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
- Age > 18 years;
- Written informed consent;
- Squamous carcinoma of the hypopharynx, larynx and oral cavity;
- Clinical stage I-IVa according to the VIII edition of AJCC staging system
- Primary surgery as first line curative intent treatment, followed by ± adjuvant radiotherapy± chemotherapy based on the pathological findings following the NCCN guidelines
Exclusion Criteria
- Relapsing or metastatic disease
- Locally advanced disease not amenable to curative intent treatment
- Previous local or systemic treatment for head and neck cancer
- Previous malignancies (exluding non-melanoma skin cancers) unless complete remission has been achieved at least 5 years before entering the study
- Psychiatric disorder or known substance abuse
- Concomitant immunosuppressive treatment
- Concomitant immunostimulant treatment
- Chronic inflammatory disease
- Autoimmune disease
- Major surgery in the previous year
- History of recent onset of any condition which, in the investigator's opinion, could interfere with patient adherence for the entire duration of the protocol.
- Positive serum pregnancy test for women of childbearing age. Women of childbearing potential (WOCBP) is defined as any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) and is not postmenopausal.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify a profile of circulating biomarkers in patients affected by HNSCC 72 months To identify a subset of patients in which biomarkers modifications might anticipate disease recurrence 72 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do circulating inflammatory biomarkers like IL-6 and CRP predict survival outcomes in HNSCC patients per NCT06809673?
What molecular pathways link systemic inflammation biomarkers to HNSCC progression in the PA.RI.GE. trial?
Can TNF-α or IL-8 levels stratify HNSCC patients for personalized immunotherapy response prediction?
How do inflammatory biomarker profiles compare to traditional prognostic factors in HNSCC clinical management?
What adverse event correlations emerge from elevated C-reactive protein in HNSCC patients undergoing standard-of-care therapies?
Trial Locations
- Locations (1)
IRCCS Policlinico San Martino
🇮🇹Genoa, Italy